An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.
Viburnum Funds Pty Ltd has ceased to be a substantial holder in Mayne Pharma Group Limited as of February 27, 2025. This change follows a series of transactions where Viburnum sold a significant number of shares, impacting its voting power and potentially affecting the company’s shareholder dynamics.
More about Mayne Pharma Group
Mayne Pharma Group Limited is a pharmaceutical company listed on the Australian Securities Exchange (ASX: MYX). It specializes in the development and manufacturing of branded and generic pharmaceutical products, focusing on oral drug delivery systems.
YTD Price Performance: 53.30%
Average Trading Volume: 2,514
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $364.5M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.